Clinical Trial Update: Investigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesis [NA]

View source ↗

Summary

The NVT ALLEGRA Plus transcatheter heart valve system trial in patients with severe aortic stenosis or failed surgical aortic bioprosthesis has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Bioprosthetic Aortic Valve Dysfunction

Drugs mentioned

• ALLEGRA Plus THV System

Snippet

Sponsor: NVT GmbH | Conditions: Transcatheter Aortic Valve Implantation | NA | Status: SUSPENDED